Trade PBM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Psyence Biomedical Ltd. Common Shares (PBM) is trading at US$4.22, down 2.31% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$16.52M. Over the past 52 weeks, PBM has traded between US$0.63 and US$22.06. On Syfe you can trade PBM with $0 commission and add it to your watchlist.
| Previous close | US$4.32 |
|---|---|
| Market cap | US$16.52M |
| 52-week range | US$0.63 – US$22.06 |
| Volume | 26.12K |
| Exchange | US |
Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.
Year: 2024
FDA Fast-Tracks Psychedelic Drug Research Following Trump Directive; Psychedelic Drug Makers Gain
Apr 24, 2:19 PM · MT Newswires
Top Premarket Decliners
Apr 22, 11:58 AM · MT Newswires
Stay on top of PBM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
